There is encouraging news for the Duchenne community as Dyne Therapeutics has announced positive top-line results from their ongoing DELIVER clinical …
Dyne Therapeutics Announces Positive Top-Line Results from DELIVER TrialRead More

16 December 2025 by John Marrin
There is encouraging news for the Duchenne community as Dyne Therapeutics has announced positive top-line results from their ongoing DELIVER clinical …
Dyne Therapeutics Announces Positive Top-Line Results from DELIVER TrialRead More

8 December 2025 by John Marrin
A significant milestone for the Duchenne community in Scotland as a new treatment option due to become available on the NHS. We are delighted to …
5 November 2025 by Lizzie Cox
We are delighted to introduce our new CEO, Katie Endacott and to share a statement from Vicky Pleydell, Chair of Trustees: "I am delighted to …
Introducing Action Duchenne’s new CEO: Katie EndacottRead More

23 October 2025 by Lizzie Cox
Action Duchenne comment on statement from NorthStar Network UK about Givinostat Firstly, and most importantly, our thoughts are with the families of …
Action Duchenne comment on statement from NorthStar Network UK about GivinostatRead More

21 October 2025 by Lizzie Cox
Community Accessibility and Support Our Community Accessibility and Support stream will run on Friday 14th November. It's designed to equip and …
10 September 2025 by John Marrin
This month there will be an opportunity for everyone interested in learning more about nutrition and Duchenne to participate in two online focus group …
DMD Care UK Nutrition Working Group – Online Focus GroupsRead More
8 September 2025 by Lizzie Cox
Urgent action needed to protect families affected by Duchenne muscular dystrophy I am deeply concerned about the devastating impact the collapse of …
6 September 2025 by Lizzie Cox
Family: The Heart of Care September 7th marks World Duchenne Awareness Day. The 7th day of the 9th month in honour of the 79 exons on the …
22 August 2025 by Mehreen Arif
On July 25th, Roche 5 the European Medicines Agency’s (EMA's) Committee for Human Medicinal Products (CHMP) unfortunately provided a negative opinion …
Update from Roche regarding Delandistrogene Moxeparvovec (Elevidys)Read More

15 August 2025 by Katie Endacott
On July 29th, Roche announced its readiness to immediately resume new orders and shipments of Elevidys for ambulatory patients outside the United …
Roche to resume Elevidys orders for ambulatory patients outside of the US Read More

7 August 2025 by John Marrin
Entrada Therapeutics has released its financial results for the second quarter of 2025, which included important updates on its clinical programs for …
Entrada Therapeutics Shares Update on Duchenne Muscular Dystrophy (DMD) ProgramsRead More
25 July 2025 by Lizzie Cox
Join us this World Duchenne Awareness Day This year the theme for World Duchenne Awareness Day is “Family: The Heart Of Care”. This theme …
Action Duchenne
2nd Floor
South
One Castle Park
Tower Hill
Bristol
BS2 OJA
0300 102 1762
info@actionduchenne.org
